GUJARAT THEMIS BIOSYN
|
The Current P/E Ratio of GUJARAT THEMIS BIOSYN is 64.52.
Share Price | ₹312.0 | Nov 22,2024 |
Market Cap | ₹3,400.3 Cr | |
Earnings-TTM | ₹52.7 Cr | TTM-Standalone Results |
Price/Earnings | 64.52x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GUJARAT THEMIS BIOSYN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,400.3 Cr] as on Nov 22,2024
(/) Earnings [ ₹52.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 64.52x ]
Thus, for GUJARAT THEMIS BIOSYN , the investors are currently willing to pay 64.52 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GUJARAT THEMIS BIOSYN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GUJARAT THEMIS BIOSYN over the last five years.
Historical PE (Price/Earnings) ratio chart of GUJARAT THEMIS BIOSYN
PE Ratio Performance Analysis for GUJARAT THEMIS BIOSYN
- GUJARAT THEMIS BIOSYN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 16.28x.
- GUJARAT THEMIS BIOSYN 's operated at median p/e ratio of 9.8x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GUJARAT THEMIS BIOSYN 's p/e ratio peaked in Mar2024 at 48.64x.
- GUJARAT THEMIS BIOSYN 's p/e ratio hit its five-year low in Mar2023 of 3.44x.
How does GUJARAT THEMIS BIOSYN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GUJARAT THEMIS BIOSYN | 52.70 | 64.52 | 3,400.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.73 | 431,352.0 |
CIPLA LTD | 4,485.22 | 26.76 | 120,035.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.73 | 101,286.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.21 | 95,461.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 86.75 | 159,265.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.11 | 102,231.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.55 | 107,306.0 |
LUPIN LTD | 2,651.94 | 35.61 | 94,430.6 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.75 | 71,069.8 |
ABBOTT INDIA LTD | 1,284.66 | 45.82 | 58,859.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GUJARAT THEMIS BIOSYN 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.73x |
Max industry PE | 86.75x |
Median industry PE | 38.73x |
Average industry PE | 42.41x |
You may also like the below Video Courses